Pathfinder Cell Therapy, Inc. (PFND)
OTCMKTS · Delayed Price · Currency is USD
0.000001
0.00 (0.00%)
At close: Dec 29, 2025
Pathfinder Cell Therapy Company Description
Pathfinder Cell Therapy, Inc. is an emerging biotechnology firm specializing in regenerative medicine.
This company is dedicated to pioneering innovative cell-based and associated treatments designed to address a range of illnesses and health issues, particularly those involving localized cellular injury within organs.
Its proprietary technology shows promise for tackling conditions such as diabetes, kidney disease, heart attacks (myocardial infarction), and peripheral vascular ailments, among others.
Established in 2008, the company maintains its corporate headquarters in Cambridge, Massachusetts.
Pathfinder Cell Therapy, Inc.
| Country | United States |
| Founded | 2008 |
| Industry | Biotechnology |
| Sector | Healthcare |
| CEO | Richard Franklin |
Contact Details
Address: 12 Bow Street Cambridge, Massachusetts Massachusetts United States | |
| Phone | 617-245-0289 |
Stock Details
| Ticker Symbol | PFND |
| Exchange | OTCMKTS |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | US70319A1060 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Dr. Richard L. Franklin M.D., Ph.D. | Founder, Chief Executive Officer, President, Secretary and Executive Director |
| Joerg Gruber | Founder and Chairman |
| John M. Benson | Chief Financial Officer and Treasurer |